Andrzej Kaszuba

Prof. Andrzej Kaszuba

Department of Dermatology, Pediatric Dermatology and Oncology Specialist Hospital Wł. Biegański Lodz
+1

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 October 2020 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
MZMichał Zimecki
Michał Zimecki
JAJolanta Artym
Jolanta Artym
WKWojciech Kalas
Wojciech Kalas
LSLeon Strządała
Leon Strządała
KKKatarzyna Kaleta-Kuratewicz
Katarzyna Kaleta-Kuratewicz
JZJanusz Zabrocki
Janusz Zabrocki
A cyclic tetrapeptide Pro-Pro-Pheβ3ho-Phe (4B8M) was tested for immunosuppressive activity and potential therapeutic utility in several in vitro and in vivo mouse and human models. The tetrapeptide was less toxic for mouse splenocytes in comparison to cyclosporine A (CsA) and a parent cyclolinopeptide (CLA). The tetrapeptide demonstrated potent anti-inflammatory properties in antigen-specific skin inflammatory reactions to oxazolone and toluene diisocyanate as well to nonspecific irritants such as salicylic acid. It also inhibited inflammatory processes in an air pouch induced by carrageenan. In addition, 4B8M proved effective in amelioration of animal models corresponding to human diseases, such as nonspecific colon inflammation induced by dextran sulfate and allergic pleurisy induced by ovalbumin (OVA) in sensitized mice. The tetrapeptide lowered expression of EP1 and EP3 but not EP2 and EP4 prostaglandin E2 (PGE2) receptors on lipopolysaccharide-stimulated Jurkat T cells and ICAM-1 expression on human peripheral blood mononuclear cells (PBMC). Its anti-inflammatory property in the carrageenan reaction was blocked by EP3 and EP4 antagonists. In addition, 4B8M induced an intracellular level of PGE2 in a human KERTr keratinocyte cell line. In conclusion, 4B8M is a low toxic and effective inhibitor of inflammatory disorders with potential therapeutic use, affecting the metabolism of prostanoid family molecules.

12 December 2019 in Materials
Verified
Journal Article
Open access
PDF file
ILIlona Latańska
Ilona Latańska
AKAnna Kozera-Żywczyk
Anna Kozera-Żywczyk
EPElwira Beata Paluchowska
Elwira Beata Paluchowska
WOWitold Owczarek
Witold Owczarek
Andrzej KaszubaAndrzej Kaszuba
Andrzej Kaszuba
WSWitold Sujka
Witold Sujka
The article presents the results of clinical trials of wound dressings whose main ingredient is butyric-acetic chitin copolyester (BAC 90:10). It is a chitin derivative soluble in typical organic solvents. During the trial, the dressings were used on wounds resulting from venous insufficiency or diabetes. The trial evaluated the safety of use and efficacy of three forms of the dressing including porous membrane (Medisorb R Membrane), porous membrane with silver (Medisorb R Ag), and powder (Medisorb R Powder). The clinical trial had a multi-centre character. Three medical units were engaged in the study. The trial included 36 patients (12 men and 24 women). The mean age of the participants was 65 years of age (age range: 26–96). The choice of dressings was made on the basis of preliminary evaluation of the wound, clinical signs of infection, or risk of infection. Medisorb R Membrane dressing was used in 23 patients, Medisorb R Ag dressing was used in 15 patients, and Medisorb R powder was used in two patients. During the course of the trial, there were 10 control visits planned. The obtained results prove the safety and efficacy of dressings in question. The efficacy of treatment was evaluated as good. In the majority of patients, the ulceration was decreased both on the surface and in depth. The success of the treatment relied not only on the applied dressing, but also the stage of the basic disease, the accompanying diseases, and the age of the patient.

1 January 2023 in Advances in Dermatology and Allergology
Verified
Journal Article
Open access
PDF file
BKBarbara Kaczmarek
Barbara Kaczmarek
MKMagdalena Kozłowska
Magdalena Kozłowska
JNJoanna Narbutt
Joanna Narbutt
ZAZygmunt Adamski
Zygmunt Adamski
KAKinga Adamska
Kinga Adamska
Andrzej KaszubaAndrzej Kaszuba
Andrzej Kaszuba
Introduction: Chronic venous insufficiency (CVI) is a widespread and serious social problem. The pathogenesis of the disease is multifactorial and one of the important factors in its development is inflammation. Aim: Assessment of the concentration of selected acute phase proteins:...